Evolution and Horizons of mRNA Therapeutics | From COVID-19 Vaccines to Cancer
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Evolution and Horizons of mRNA Therapeutics | From COVID-19 Vaccines to Cancer
-
Letto da:
-
Di:
A proposito di questo titolo
The rapid rise of mRNA technology during the COVID-19 pandemic marked a turning point in modern medicine. But mRNA therapeutics go far beyond vaccines.
In this BCI podcast episode, we explore the evolution, breakthroughs, and future horizons of mRNA-based drugs—from their early development to their expanding role in cancer immunotherapy, infectious disease prevention, and protein replacement therapies.
We discuss:
• How COVID-19 vaccines accelerated global mRNA research
• The “double-edged sword” of immunogenicity
• Why immune activation is beneficial for vaccines but problematic for other treatments
• The growing importance of personalized medicine
• How age, gender, and underlying health conditions influence mRNA drug response
• Major technical challenges, including delivery systems and tissue-specific targeting
• The future of mRNA technology in precision medicine
As mRNA platforms continue to evolve, they are reshaping the landscape of biotechnology and therapeutic innovation. This episode provides a comprehensive overview of where the science stands today—and where it’s headed next.
🎙️ Tune in to understand how mRNA is transforming modern medicine.
#BCIPodcast #mRNATherapeutics #Biotechnology